{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:18:29Z","timestamp":1791256709825,"version":"4.1.0"},"reference-count":44,"publisher":"EDP Sciences","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1051\/medsci\/2010265516","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T06:09:06Z","timestamp":1299305346000},"page":"516-521","source":"Crossref","is-referenced-by-count":19,"title":["GSK-3\u03b2 : une kinase au c\u0153ur des maladies neuro-d\u00e9g\u00e9n\u00e9ratives\u00a0?"],"prefix":"10.1051","volume":"26","author":[{"given":"Agnes","family":"Petit-Paitel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"250","published-online":{"date-parts":[[2010,5,15]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.Prog Neurobiol2001; 65 : 391\u2013426.","DOI":"10.1016\/S0301-0082(01)00011-9"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Leroy K, Yilmaz Z, Brion JP. Increased level of active GSK-3beta in Alzheimer\u2019s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration.Neuropathol Appl Neurobiol2007; 33 : 43\u201355.","DOI":"10.1111\/j.1365-2990.2006.00795.x"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Brownlees J, Irving NG, Brion JP,et al.Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenes.Neuroreport1997; 8 : 3251\u20135.","DOI":"10.1097\/00001756-199710200-00013"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Engel T, Hernandez F, Avila J,et al.Full reversal of Alzheimer\u2019s disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3.J Neurosci2006; 26 : 5083\u201390.","DOI":"10.1523\/JNEUROSCI.0604-06.2006"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Aplin AE, Gibb GM, Jacobsen JS,et al.In vitrophosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3beta.J Neurochem1996; 67 : 699\u2013707.","DOI":"10.1046\/j.1471-4159.1996.67020699.x"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Qing H, He G, Ly PT,et al.Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer\u2019s disease mouse models.J Exp Med2008; 205 : 2781\u20139.","DOI":"10.1084\/jem.20081588"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Su Y, Ryder J, Li B,et al.Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing.Biochemistry2004; 43 : 6899\u2013908.","DOI":"10.1021\/bi035627j"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Terwel D, Muyllaert D, Dewachter I,et al.Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice.Am J Pathol2008; 172 : 786\u201398.","DOI":"10.2353\/ajpath.2008.070904"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Checler F, Alves da Costa C, Dumanchin-Njock C,et al.M\u00e9tabolisme du pr\u00e9curseur du peptide amylo\u00efde et pr\u00e9s\u00e9nilines.Med Sci (Paris)2002; 18 : 717\u201324.","DOI":"10.1051\/medsci\/20021867717"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Takashima A, Murayama M, Murayama O,et al.Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau.Proc Natl Acad Sci USA1998; 95 : 9637\u201341.","DOI":"10.1073\/pnas.95.16.9637"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Murayama M, Tanaka S, Palacino J,et al.Direct association of presenilin-1 with beta-catenin.FEBS Lett1998; 433 : 73\u20137.","DOI":"10.1016\/S0014-5793(98)00886-2"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Rockenstein E, Torrance M, Adame A,et al.Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer\u2019s disease are associated with reduced amyloid precursor protein phosphorylation.J Neurosci2007; 27 : 1981\u201391.","DOI":"10.1523\/JNEUROSCI.4321-06.2007"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Nakashima H, Ishihara T, Suguimoto P,et al.Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies.Acta Neuropathol2005; 110 : 547\u201356.","DOI":"10.1007\/s00401-005-1087-4"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Engel T, Goni-Oliver P, Lucas JJ,et al.Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.J Neurochem2006; 99 : 1445\u201355.","DOI":"10.1111\/j.1471-4159.2006.04139.x"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Caccamo A, Oddo S, Tran LX,et al.Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles.Am J Pathol2007; 170 : 1669\u201375.","DOI":"10.2353\/ajpath.2007.061178"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Hu S, Begum AN, Jones MR,et al.GSK3 inhibitors show benefits in an Alzheimer\u2019s disease (AD) model of neurodegeneration but adverse effects in control animals.Neurobiol Dis2009; 33 : 193\u2013206.","DOI":"10.1016\/j.nbd.2008.10.007"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Jope RS, Bijur GN. Mood stabilizers, glycogen synthase kinase-3beta and cell survival.Mol Psychiatry2002; 7 (suppl 1) : S35\u201345.","DOI":"10.1038\/sj.mp.4001017"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Gomez-Sintes R, Hernandez F, Bortolozzi A,et al.Neuronal apoptosis and reversible motor deficit in dominant-negative GSK-3 conditional transgenic mice.EMBO J2007; 26 : 2743\u201354.","DOI":"10.1038\/sj.emboj.7601725"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Peineau S, Taghibiglou C, Bradley C,et al.LTP inhibits LTD in the hippocampus via regulation of GSK3beta.Neuron2007; 53 : 703\u201317.","DOI":"10.1016\/j.neuron.2007.01.029"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Bell EC, Willson MC, Wilman AH,et al.Differential effects of chronic lithium and valproate on brain activation in healthy volunteers.Hum Psychopharmacol2005; 20 : 415\u201324.","DOI":"10.1002\/hup.710"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Martinez A, Perez DI. GSK-3 inhibitors: a ray of hope for the treatment of Alzheimer\u2019s disease ?J Alzheimers Dis2008; 15 : 181\u201391.","DOI":"10.3233\/JAD-2008-15204"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Dagda RK, Zhu J, Chu CT. Mitochondrial kinases in Parkinson\u2019s disease: Converging insights from neurotoxin and genetic models.Mitochondrion2009; 9 : 289\u201398.","DOI":"10.1016\/j.mito.2009.06.001"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Nagao M, Hayashi H. Glycogen synthase kinase-3beta is associated with Parkinson\u2019s disease.Neurosci Lett2009; 449 : 103\u20137.","DOI":"10.1016\/j.neulet.2008.10.104"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Wang W, Yang Y, Ying C,et al.Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity.Neuropharmacology2007; 52 : 1678\u201384.","DOI":"10.1016\/j.neuropharm.2007.03.017"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Petit-Paitel A, Brau F, Cazareth J,et al.Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP\/MPP-treated neurons.PLoS One2009; 4 : e5491.","DOI":"10.1371\/journal.pone.0005491"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Arima K, Hirai S, Sunohara N,et al.Cellular co-localization of phosphorylated tau- and NACP\/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson\u2019s disease and in dementia with Lewy bodies.Brain Res1999; 843 : 53\u201361.","DOI":"10.1016\/S0006-8993(99)01848-X"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Duda JE, Giasson BI, Mabon ME,et al.Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred.Acta Neuropathol2002 : 104 : 7\u201311.","DOI":"10.1007\/s00401-002-0563-3"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Duka T, Duka V, Joyce J N,et al.Alpha-synuclein contributes to GSK-3(beta)-catalyzed Tau phosphorylation in Parkinson\u2019s disease models.Faseb J2009; 23 : 2820\u201330.","DOI":"10.1096\/fj.08-120410"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Ribeiro CS, Carneiro K, Ross CA,et al.Synphilin-1 is developmentally localized to synaptic terminals, and its association with synaptic vesicles is modulated by alpha-synuclein.J Biol Chem2002; 277 : 23927\u201333.","DOI":"10.1074\/jbc.M201115200"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Coux O, Piechaczyk M. Le syst\u00e8me ubiquitine\/prot\u00e9asome : un ensemble (de) complexe(s) pour d\u00e9grader les prot\u00e9ines.Med Sci (Paris)2000; 16 : 623\u20139.","DOI":"10.4267\/10608\/1705"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Avraham E, Szargel R, Eyal A,et al.Glycogen synthase kinase 3beta modulates synphilin-1 ubiquitylation and cellular inclusion formation by SIAH: implications for proteasomal function and Lewy body formation.J Biol Chem2005 : 280 : 42877\u201386.","DOI":"10.1074\/jbc.M505608200"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Park SS, Zhao H, Mueller RA,et al.Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta.J Mol Cell Cardiol2006; 40 : 708\u201316.","DOI":"10.1016\/j.yjmcc.2006.01.024"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Youdim MB, Arraf Z. Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax.Neuropharmacology2004; 46 : 1130\u201340.","DOI":"10.1016\/j.neuropharm.2004.02.005"},{"key":"R34","doi-asserted-by":"crossref","unstructured":"Carmichael J, Sugars KL, Bao YP,et al.Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington\u2019s disease mutation.J Biol Chem2002; 277 : 33791\u20138.","DOI":"10.1074\/jbc.M204861200"},{"key":"R35","doi-asserted-by":"crossref","unstructured":"Sarkar S, Ravikumar B, Floto RA,et al.Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies.Cell Death Differ2009; 16 : 46\u201356.","DOI":"10.1038\/cdd.2008.110"},{"key":"R36","doi-asserted-by":"crossref","unstructured":"Yang W, Leystra-Lantz C, Strong MJ. Upregulation of GSK3beta expression in frontal and temporal cortex in ALS with cognitive impairment (ALSci).Brain Res2008; 1196 : 131\u20139.","DOI":"10.1016\/j.brainres.2007.12.031"},{"key":"R37","doi-asserted-by":"crossref","unstructured":"Feng HL, Leng Y, Ma CH,et al.Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model.Neuroscience2008; 155 : 567\u201372.","DOI":"10.1016\/j.neuroscience.2008.06.040"},{"key":"R38","doi-asserted-by":"crossref","unstructured":"Perez M, Rojo AI, Wandosell F,et al.Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3.Biochem J2003; 372 : 129\u201336.","DOI":"10.1042\/bj20021596"},{"key":"R39","doi-asserted-by":"crossref","unstructured":"Heiseke A, Aguib Y, Riemer C,et al.Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy.J Neurochem2009; 109 : 25\u201334.","DOI":"10.1111\/j.1471-4159.2009.05906.x"},{"key":"R40","doi-asserted-by":"crossref","unstructured":"Andreu P, Perret C, Romagnolo B. Wnt et cellules souches intestinales : des liaisons dangereuseMed Sci (Paris)2006; 22 : 693\u20135.","DOI":"10.1051\/medsci\/20062289693"},{"key":"R41","doi-asserted-by":"crossref","unstructured":"Clavaguera F, Goedert M, Tolnay M. Induction et propagation de la pathologie par la prot\u00e9ine tau chez un mod\u00e8le murin de la maladie d\u2019Alzheimer.Med Sci (Paris)2010; 26 : 123\u20134.","DOI":"10.1051\/medsci\/2010262121"},{"key":"R42","doi-asserted-by":"crossref","unstructured":"Corti O, Brice A. La maladie de Parkinson: que nous apprennent les g\u00e8nes responsables des formes familiales ?Med Sci (Paris)2003; 19 : 613\u20139.","DOI":"10.1051\/medsci\/2003195613"},{"key":"R43","doi-asserted-by":"crossref","unstructured":"Langui D, Lachapelle F, Duyckaerts C. Mod\u00e8les animaux des maladies neuro-d\u00e9g\u00e9n\u00e9ratives.Med Sci (Paris)2007; 23 : 180\u20136.","DOI":"10.1051\/medsci\/2007232180"},{"key":"R44","doi-asserted-by":"crossref","unstructured":"Lelan F, Damier P. Les neurones dopaminergiques greff\u00e9s dans la maladie de Parkinson sont-il \u00e0 leur tour atteints par le processus d\u00e9g\u00e9n\u00e9ratif ?Med Sci (Paris)2009; 25 : 15\u20136.","DOI":"10.1051\/medsci\/200925115"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2010265516\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T00:42:54Z","timestamp":1560040974000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2010265516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":44,"journal-issue":{"issue":"5"},"alternative-id":["medsci2010265p516"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/2010265516","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}